A randomized controlled trial of Telitacicept in the treatment of IgA nephropathy after kidney transplantation

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: f60ed8a630508c70b0650f266741583eff6563ea
First added on: Apr 08, 2025